《全日總結》恆指升204點 美團漲逾5% 藥明系造高
市場觀望美國通脹數據,道指升170點或0.5%。港股今日回升。恆指高開56點後升幅擴大,曾升362點一度高見16,459點,全日升204點或1.3%,收16,302點;國指升73點或1.4%,收5,494點;恆生科技指數升74點或2.2%,收3,503點。大市全日成交總額937.17億元,滬、深港通南下交易淨流出9.2億及23.87億元人民幣。
藥明生物(02269.HK)料今年新增專案目標由80個升至110個,股價升8.8%,爲升幅最大藍籌。同系藥明康德(02359.HK)全日升6.7%。其他醫藥股方面,石藥(01093.HK)挫6.2%,爲跌幅最大藍籌。金斯瑞(01548.HK)及康龍化成(03759.HK)漲5.9%及5.2%,百濟神州(06160.HK)跌4.3%。
科技股方面,美團(03690.HK)首度回購涉資4億元,股價升5.4%報75.6元。阿里(09988.HK)、騰訊(00700.HK)、小米(01810.HK)及嗶哩嗶哩(09626.HK)升2.2%至2.7%。京東(09618.HK)升1.7%。百度(09888.HK)、網易(09999.HK)及快手(01024.HK)升不足1%。此外,金蝶(00268.HK)及美圖(01357.HK)升6%及4.2%,閱文(00772.HK)漲7.7%,東方甄選(01797.HK)則吐3.7%。
車股比亞迪(01211.HK)、理想(02015.HK)及長汽(02333.HK)升3.8%至5.1%,小鵬(09868.HK)升3.1%。消費內需股方面,貓眼娛樂(01896.HK)及中免(01880.HK)升3.2%及4%,特步(01368.HK)升5.1%。報道指海底撈(06862.HK)元旦三天假期接待顧客人次按年升70%,該股昨日(10日)炒升逾8%,全日回跌0.8%報14.32元。
本地地產股新世界(00017.HK)、太古地產(01972.HK)及九倉置業(01997.HK)升3.1%至3.8%。內房股綠城中國(03900.HK)、旭輝(00884.HK)、合景泰富(01813.HK)及融創中國(01918.HK)升3.7%至4.5%。遠洋集團(03377.HK)據報提出境內債展期方案,股價升1.3%,金融股方面,匯控(00005.HK)升0.2%,港交所(00388.HK)及友邦(01299.HK)升1.9%及1%,內險股中國平安(02318.HK)升2.8%,內銀股招行(03968.HK)升1.6%。
盈富基金(02800.HK)升1.3%報16.46元,全日成交近113.5億元,按日升3倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.